For patients who received a letter on improperly disclosed information by a claims processing vendor, read more.

Excellence is just the beginning.


French German Italian Portuguese Russian

Cognitive Neuropsychology of HIV and Drug Abuse Study

Clinical Trial Title: 
Cognitive neuropsychology of HIV and drug abuse.
Clinical Trial Protocol ID: 
Clinical Trial Investigator Name: 
Eileen Martin, PhD
Clinical Trial Protocol Description: 

The purpose of this prospective study is to investigate sex differences in the effects of HIV/AIDS and substance abuse on the brain and neurocognitive functions such as memory and decision-making. The study consists of 2 paid visits to RUMC that include paper and pencil and computerized cognitive tasks. At Rush University Medical center we expect to recruit approximately 500 participants.

Please note this project is a prospective study, not a clinical trial.

Clinical Trial Eligibility Criteria: 

In order to participate you must meet the following criteria:

  • Are age 18 – 60 with at least 8 years of education.
  • Have used cocaine or heroin.
  • Are willing to provide urine specimen for drug screen.

You will be excluded from the study if any of the following criteria apply to you:

  • Test positive for drugs on urine screening.

This is a partial list of inclusion and exclusion criteria.

Clinical Trial Area: 
Mental Health Disorders
Contact Phone: 
(312) 563-6639
Contact Name: 
Lorraine Gibson